Picture of Biocure Technology logo

CURE Biocure Technology Income Statement

0.000.00%
ca flag iconLast trade - 00:00
EnergyHighly SpeculativeMicro Cap

Annual income statement for Biocure Technology, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
R2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Total Revenue00000
Cost of Revenue
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses6.594.733.121.860.408
Operating Profit-6.59-4.73-3.12-1.86-0.408
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-6.59-4.79-3.08-1.87-0.403
Net Income After Taxes-6.59-4.79-3.08-1.87-0.403
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income-6.59-4.74-2.95-1.13-1.45
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-6.59-4.74-2.95-1.13-1.45
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-0.068-0.049-0.032-0.018-0.006